Veterinary Vaccines Market

Veterinary Vaccines Market worth $8.7 billion by 2022

The Veterinary Vaccines Market is estimated to grow from USD 6.5 billion in 2017 to USD 8.7 billion by 2022, at a CAGR of 5.9%. The growth in this market is driven majorly by the increasing adoption of companion animals, rising prevalence of zoonotic diseases, new product launches, and an increase in the livestock population.

Browse 148 market data tables and 26 figures spread through 161 pages and in-depth TOC on "Veterinary/Animal Vaccines Market Type (Porcine, Poultry, Companion Animal, Aquaculture), Disease (Porcine Parvovirus, Swine Pneumonia, Avian Influenza, Rabies, Clostridial Diseases), Technology (Inactivated, Toxoid, Recombinant) - Global Forecast to 2022"
View detailed Table of Content here - https://www.marketsandmarkets.com/Market-Reports/animal-veterinary-vaccines-market-1233.html

Porcine vaccines commanded the largest share of the veterinary vaccines market, by type, in 2017

By type, the veterinary vaccines market is segmented into porcine vaccines, poultry vaccines, livestock vaccines, companion animal vaccines, aquaculture vaccines, and other animal vaccines. In 2017, the porcine vaccines segment accounted for the largest market share. This is primarily due to the increasing porcine population and increasing outbreaks of porcine diseases such as PRRS (porcine reproductive & respiratory syndrome), swine influenza, and Aujeszkys disease (AD).

Recombinant vaccines are the fastest-growing technology segment in the veterinary vaccines market

The veterinary vaccines market, by technology, is segmented into live attenuated vaccines, inactivated vaccines, toxoid vaccines, recombinant vaccines, and other vaccines. The recombinant vaccines segment is projected to register the highest CAGR during the forecast period. Recombinant vaccines are free from pathogen contamination, exhibit no post-vaccination reactions, and are safer to use as there is no risk of contracting a disease from the agent. These advantages are expected to support the growth of the recombinant vaccines segment in the coming years.

Europe will continue to dominate the veterinary vaccines market in 2022

In 2017, Europe accounted for the largest share of the veterinary vaccines market, followed by North America. The large share of this regional segment can primarily be attributed to the increasing companion animal ownership in the region and the growing focus on improving animal health and productivity.
Prominent players in the veterinary vaccines market are Zoetis (US), Merck Animal Health (US), Elanco (US), Boehringer Ingelheim (Germany), Ceva (France), Phibro Animal Health (US), Virbac (France), Vetoquinol (France), Hester (India), and HIPRA (Spain).

Don’t miss out on business opportunities in Veterinary/Animal Vaccines Market. Speak to our analyst and gain crucial industry insights that will help your business grow.

About MarketsandMarkets™

MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

MarketsandMarkets’s flagship competitive intelligence and market research platform, "Knowledgestore" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

Contact:
Mr. Shelly Singh
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
sales@marketsandmarkets.com

Report Code
PH 3475
PR Published ON
7/26/2019
Choose License Type
BUY NOW
  • SHARE
X
Request Customization
Speak to Analyst
Speak to Analyst
OR FACE-TO-FACE MEETING
PERSONALIZE THIS RESEARCH
  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
REQUEST A FREE CUSTOMIZATION
LET US HELP YOU!
  • What are the Known and Unknown Adjacencies Impacting the Veterinary Vaccines Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
REQUEST A FREE WORKSHOP
ADJACENT MARKETS
REQUEST BUNDLE REPORTS
ONLINE CHAT
+1-888-600-6441
  • Call Us
  • +1-888-600-6441 (Corporate office hours)
  • +1-888-600-6441 (US/Can toll free)
  • +44-800-368-9399 (UK office hours)
CONNECT WITH US
ABOUT TRUST ONLINE
© MarketsandMarkets Research Private Ltd. All rights reserved
...

Digital Virtual Assistant - MarketsandMarkets

Home